Schwarzschild MA - Search Results

1

Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton AB, Barker RA, Kieburtz K, Olanow CW, Lozano A, Kordower JH, Cedarbaum JM, Brundin P, Standaert DG, Lang AE. Espay AJ, et al. Among authors: schwarzschild ma. Neurology. 2020 Mar 17;94(11):481-494. doi: 10.1212/WNL.0000000000009107. Epub 2020 Feb 26. Neurology. 2020. PMID: 32102975 Free PMC article. Review.

2

Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors.

Chen JF, Beilstein M, Xu YH, Turner TJ, Moratalla R, Standaert DG, Aloyo VJ, Fink JS, Schwarzschild MA. Chen JF, et al. Among authors: schwarzschild ma. Neuroscience. 2000;97(1):195-204. doi: 10.1016/s0306-4522(99)00604-1. Neuroscience. 2000. PMID: 10771351

3

Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.

Schwarzschild MA, Chen JF, Ascherio A. Schwarzschild MA, et al. Neurology. 2002 Apr 23;58(8):1154-60. doi: 10.1212/wnl.58.8.1154. Neurology. 2002. PMID: 11971080 Review.

4

Caffeine, postmenopausal estrogen, and risk of Parkinson's disease.

Ascherio A, Chen H, Schwarzschild MA, Zhang SM, Colditz GA, Speizer FE. Ascherio A, et al. Among authors: schwarzschild ma. Neurology. 2003 Mar 11;60(5):790-5. doi: 10.1212/01.wnl.0000046523.05125.87. Neurology. 2003. PMID: 12629235

5

Alcohol consumption and the incidence of Parkinson's disease.

Hernán MA, Chen H, Schwarzschild MA, Ascherio A. Hernán MA, et al. Among authors: schwarzschild ma. Ann Neurol. 2003 Aug;54(2):170-5. doi: 10.1002/ana.10611. Ann Neurol. 2003. PMID: 12891669

6

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

Chen H, Zhang SM, Hernán MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A. Chen H, et al. Among authors: schwarzschild ma. Arch Neurol. 2003 Aug;60(8):1059-64. doi: 10.1001/archneur.60.8.1059. Arch Neurol. 2003. PMID: 12925360

7

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease.

Bibbiani F, Oh JD, Petzer JP, Castagnoli N Jr, Chen JF, Schwarzschild MA, Chase TN. Bibbiani F, et al. Among authors: schwarzschild ma. Exp Neurol. 2003 Nov;184(1):285-94. doi: 10.1016/s0014-4886(03)00250-4. Exp Neurol. 2003. PMID: 14637099

8

Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.

Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG. Dunah AW, et al. Among authors: schwarzschild ma. Mol Pharmacol. 2004 Jan;65(1):121-9. doi: 10.1124/mol.65.1.121. Mol Pharmacol. 2004. PMID: 14722243

9

Physical activity and the risk of Parkinson disease.

Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Chen H, et al. Among authors: schwarzschild ma. Neurology. 2005 Feb 22;64(4):664-9. doi: 10.1212/01.WNL.0000151960.28687.93. Neurology. 2005. PMID: 15728289

10

Pesticide exposure and risk for Parkinson's disease.

Ascherio A, Chen H, Weisskopf MG, O'Reilly E, McCullough ML, Calle EE, Schwarzschild MA, Thun MJ. Ascherio A, et al. Among authors: schwarzschild ma. Ann Neurol. 2006 Aug;60(2):197-203. doi: 10.1002/ana.20904. Ann Neurol. 2006. PMID: 16802290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page